University of California San Diego Health

UC San Diego Partners with San Ysidro Health to Expand COVID-19 Testing

$5 million grant from National Institutes of Health will fund program to use expansive, new testing platform to assess and assist underserved communities hard-hit by the pandemic

Newswise — Researchers at University of California San Diego School of Medicine, in collaboration with local partners, have been awarded a $5 million grant from the National Institutes of Health (NIH) to implement a program of widespread testing for COVID-19 in San Ysidro, focused on pregnant women and children.

The two-year program, headed by Robert Tukey, PhD, professor of pharmacology, and Louise Laurent, MD, PhD, professor of obstetrics, gynecology and reproductive sciences, is part of the NIH’s Rapid Acceleration of Diagnostics (RADx) Initiative for COVID-19.

“There is growing concern nationwide that asymptomatic, presymptomatic and mildly symptomatic children and adolescents may be unknowingly spreading COVID-19 infections to highly vulnerable populations — at home, at school and in their communities,” said Tukey, who also directs the UC San Diego Superfund Research Center.

Across the country, communities of color have been disproportionately impacted by the pandemic. Like other diverse, low-income, and underserved communities, San Ysidro is particularly susceptible to the effects of SARS-CoV-2, the virus that causes COVID-19. The population is young and largely Hispanic, with one-third of residents under 18 years of age. Many residents live in large, multi-generational homes that may exacerbate viral transmission rates.

The San Ysidro Port of Entry is also among the busiest border crossings in the world, with an estimated 50,000 vehicles and 25,000 pedestrians crossing from Mexico into the United States each day.

San Diego County Health and Human Services estimates the infection case rate in San Ysidro at nearly 6,000 per 100,000 population, four times greater than the San Diego County average (approximately 1,400 per 100,000 population). However, accurate numbers are difficult to obtain because access to testing and contact tracing have been insufficient.

Laurent said UC San Diego and San Ysidro Health (SYH) have an established history of successful health care and research collaborations, with each bringing key strengths. In particular, the UC San Diego Superfund Research Center has a long-standing relationship with vulnerable and underserved communities in San Diego. SYH is a well-recognized and highly trusted provider of comprehensive health care, encompassing 41 program sites that provide medical, dental and behavioral health services and school-based care to more than 105,000 patients throughout San Diego County.

A third partner — The Global Action Research Center (Global ARC) — will work with community members, the research team’s implementation science experts and other key participants to identify and address concerns people may have about the safety and usefulness of testing. Global ARC is a nonprofit organization that specializes in connecting academic-based knowledge, technologies and programs with communities in need.

The testing effort will be conducted through the UC San Diego Biochemical Genetics and Metabolomics Laboratory under the direction of Laurent, Rob Knight, PhD, professor and director of the Center for Microbiome Innovation and Gene Yeo, PhD, professor of cellular and molecular medicine, all at UC San Diego School of Medicine. It will employ an automated testing system capable of processing up to 6,000 tests per day at one-third the cost of current clinical COVID-19 tests.

Tukey noted, however, that greater testing capacity doesn’t automatically translate into more people being tested.

“This project will also apply ‘implementation science’ — an evidence-based approach to finding new ways to connect and communicate with persons and communities of color who have long suffered from systemic racism, health inequities and lack of resources. One of the most important aspects of this grant is the substantial support it provides to get serious about understanding factors that have led to disproportionate burden of the pandemic on underserved populations so that interventions can be implemented to decrease these disparities.”

Global ARC will lead a process with community members to develop a “Theory of Change,” an inclusive, participatory method to identify ‘pathways to impact’ for research projects. Theory of Change builds teamwork, while gaining consensus around the identification of root causes of the local obstacles facing effective and efficient testing within underserved communities.

“This process will identify and characterize barriers to testing uptake, including stigma, distrust, fear, discrimination and lack of scientific knowledge — and develop a set of interventions to mitigate the effects of these barriers regarding COVID-19 testing in clinical and community settings,” said Laurent.

“It will also document the extent to which factors at multiple levels, such as environmental public health policies, strength of local civic engagement and interpersonal/family and individual variables impact rates of morbidity and mortality”.

Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Showing results

110 of 4146